HIND: Vyome Holdings, Inc. Common Stock Company Profile & Statistics

Vyome Holdings, Inc. Common Stock Profile

About

Vyome Therapeutics Inc. is a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases principally in the US. Vyome Therapeutics Inc., formerly known as ReShape Lifesciences Inc., is based in CAMBRIDGE, Mass.

Info & Links

CEO

Paul F. Hickey

Headquarters

18 Technology Dr, Suite 110
Irvine, CA 92618, UNITED STATES

Auditor

Haskell & White LLP

Share holders

Employees

Vyome Holdings, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

143.44M

Enterprise Value

139.22M

Enterprise Value/EBITDA(ttm)

-16.75

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.58

Price to Book(mrq)

0.56

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

61.32%

Operating Margin(ttm)

-69.71%

Profit Margin(ttm)

-61.47%

Return on Equity(ttm)

-216.95%

Return on Invested Capital(ttm)

664.44%

Return on Assets(ttm)

-69.42%

Income Statement

Revenue(ttm)

6.45M

Revenue Per Share(ttm)

9.58

Gross Profit(ttm)

4.04M

EBITDA(ttm)³

-8.31M

Net Income Available to Common(ttm)

-4.50M

Diluted EPS(ttm)

-433.08

Share Statistics

Beta (5Y Monthly)

1.05

52-Week Change

S&P 500 52-Week Change

17.90%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

673.34K

Dividend Yield

0.00%

Float⁴

673.00K

% Held by Insiders

0.01%

% Held by Institutions

22.06%

Balance Sheet

Total Cash(mrq)

4.22M

Total Cash Per Share(mrq)

6.27

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.77%

Quick Ratio(mrq)

1.97%

Book Value Per Share(mrq)

8.89

Cash Flow

Operating Cash Flow Per Share(ytd)

-22.63

Free Cash Flow(ytd)

-6.61M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

HIND

Vyome Holdings, Inc. Common Stock